Douglas J Swirsky Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Douglas J Swirsky.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Douglas J Swirsky. Douglas J Swirsky is a Director in Fibrocell Science, Inc. ($FCSC) and a Director in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA) and a Chief Financial Officer in GENVEC INC ($GNVC) and a President & CEO in GENVEC INC ($GNVC) and a President and CEO in GENVEC INC ($GNVC) and a President and CEO in REXAHN PHARMACEUTICALS, INC. ($RNN) and a President and CFO in REXAHN PHARMACEUTICALS, INC. ($RNN) and a Director in Cellectar Biosciences, Inc. ($CLRB) and a Director in NeuroBo Pharmaceuticals, Inc. ($GEMP).

Address: 65 WEST WATKINS MILL ROAD GAITHERSBURG 20878 MD

Companies in which Douglas J Swirsky is an Insider

Cellectar Biosciences, Inc.

Trading Symbol: CLRB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas J Swirsky: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 25 2020
$CLRB Market Capitalization: $9.82M
$CLRB Previous Close: $1.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Fibrocell Science, Inc.

Trading Symbol: FCSC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas J Swirsky: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2019
$FCSC Market Capitalization: $30.78M
$FCSC Previous Close: $0.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENVEC INC

Trading Symbol: GNVC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas J Swirsky: President and CEO, President & CEO, Chief Financial Officer
Holdings: 50,250 shares
Current Value: $321,600
Latest Transaction: Jun 20 2017
$GNVC Market Capitalization: $14.75M
$GNVC Previous Close: $6.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NeuroBo Pharmaceuticals, Inc.

Trading Symbol: NRBO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas J Swirsky: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 03 2020
$NRBO Market Capitalization: $97.34M
$NRBO Previous Close: $10.72

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ocuphire Pharma, Inc.

Trading Symbol: RNN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas J Swirsky: President and CEO, President and CFO
Holdings: 50,000 shares
Current Value: $9,000
Latest Transaction: Jan 30 2019
$RNN Market Capitalization: $41.78M
$RNN Previous Close: $0.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PERNIX THERAPEUTICS HOLDINGS, INC.

Trading Symbol: GTA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas J Swirsky: Director
Holdings: 0 shares
Latest Transaction: May 23 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Douglas J Swirsky

Sentiment: All, CLRB, FCSC, GNVC, NRBO, RNN, GTA

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 03 2020GEMPNeuroBo Pharmaceut ...Swirsky Douglas JDirectorOption ExerciseA6.0460,000362,40060,000
Jun 25 2020CLRBCellectar Bioscien ...Swirsky Douglas JDirectorOption ExerciseA1.2880,000102,40080,000
Dec 13 2019FCSCFibrocell Science, ...Swirsky Douglas JDirectorOption ExerciseD1.9412,00023,2800
Dec 13 2019FCSCFibrocell Science, ...Swirsky Douglas JDirectorOption ExerciseD2.366,00014,1600
Dec 13 2019FCSCFibrocell Science, ...Swirsky Douglas JDirectorOption ExerciseD16.556,00099,3000
Dec 13 2019FCSCFibrocell Science, ...Swirsky Douglas JDirectorOption ExerciseD14.252,40034,2000
Dec 13 2019FCSCFibrocell Science, ...Swirsky Douglas JDirectorOption ExerciseD81.602,400195,8400

View all Douglas J Swirsky insider transactions.